Merit Medical acquires EndoGastric Solutions' EsophyX Z+ device for $105M; updates 2024 guidance

MERIT MEDICAL SYSTEMS INC

Asset purchase of EsophyX Z+ device for $105M cash, financed via credit facility draws.
Projected to add ~$30M annualized revenue, leveraging existing GI endoscopy commercial footprint.
Modestly dilutive to full-year 2024 non-GAAP profitability but expected accretive in first full year post-closing.
Reaffirmed standalone 2024 guidance; updated outlook to include partial-year impact; details on Aug 1 Q2 call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.